Indication
Myotonic Dystrophy Type 1
The Myotonic Dystrophy Type 1 pipeline: 3 tracked drugs.
Coverage in progress.The assets here come from their companies' published pipelines. AssetMemo has not yet run its full census of every drug in development for Myotonic Dystrophy Type 1, so this list is not complete.
1 Phase 22 preclinical / unstaged
Compare the share prices of listed companies in Myotonic Dystrophy Type 1 →
Market size not yet sourced. How markets are sized ↗